We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Thrombotargets and Instituto Biomar Sign Drug Discovery Collaboration

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Thrombotargets Corp and Instituto Biomar have announced the signature of a drug discovery collaboration agreement.

Under the terms of this agreement, Instituto Biomar will provide Thrombotargets Corp with its libraries of purified natural products and extracts collection for its High Throughput Screening of Pathway Activity (HTS-PA) in Thrombotargets’ technology.

Thrombotargets will seek to identify and optimize drug candidates for multiple targets that will be jointly developed by both companies.